Who founded Automera?

Automera was founded by Zian-Loong Wang, Michael Lazarou.

Who are Automera's investors?

Automera's investors include ACCELERATOR LIFE SCIENCE PARTNERS, ClavystBio, Xora Innovation Pte Ltd.

How much funding has Automera raised?

Automera has disclosed $16M raised across 1 of its 2 known rounds.

Automera

5 known investors

Find your way into Automera

Paths you didn't know you had: your email and LinkedIn already hold routes to the Automera team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation. The company targets pharmaceutical and biotech organizations seeking novel technologies for small molecule drug discovery.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Zian-Loong WangChief Technology Officer & Co-Founder

Michael LazarouCo-Founder

Thong Q. Le Chief Executive OfficerThong Q. Le is Chief Executive Officer of Automera, which develops an autophagy-powered small molecule degrader platform for drug discovery. He brings over 25 years of life sciences investment experience, including roles as Senior Managing Director and Chairman of Accelerator Life Science Partners (a venture capital firm he joined in 2013) and Managing Director at WRF Capital, where he supported early-stage life sciences companies; he holds an A.B. in Government from Harvard University and postgraduate business studies from Templeton College, Oxford University.

Investors · 5

ACCELERATOR LIFE SCIENCE PARTNERS✓ confirmed by AutomeraSeattle

How we know: the company's own site · funding news · kr-asia.com · Not right? Tell us

ClavystBiolisted by ClavystBioSingapore

How we know: ClavystBio's portfolio page · funding news · technode.global · Not right? Tell us

Xora Innovation Pte LtdreportedSingapore

How we know: funding news · kr-asia.com · Not right? Tell us

Also in the syndicate · 2

ALSPleadEDBI

Funding

SEC filings, press & company announcements

$16M disclosed across 1 of 2 rounds · 2023

$16MSeries ASep 2023 · 5 sources
Accelerator Life Science Partners (ALSP) (lead), ALSP (lead), ClavystBio (lead), EDBI, Xora Innovation
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Automera Raises $16M in Series A Fundingfinsmes.com · Sep 2023

Frequently asked questions

What does Automera do?: Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation. The company targets pharmaceutical and biotech organizations seeking novel technologies for small molecule drug discovery.
Who founded Automera?: Automera was founded by Zian-Loong Wang, Michael Lazarou.
Who are Automera's investors?: Automera's investors include ACCELERATOR LIFE SCIENCE PARTNERS, ClavystBio, Xora Innovation Pte Ltd.
How much funding has Automera raised?: Automera has disclosed $16M raised across 1 of its 2 known rounds.